BACTERIAL VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Bacterial Vaccines Market, By Vaccine Type (Pertussis (Whooping Cough) Vaccines, Tetanus Vaccines, Diphtheria Vaccines, Pneumococcal Vaccines, Meningococcal Vaccines, Typhoid Vaccines, Tuberculosis (TB) Vaccines, Cholera Vaccines, Shigellosis Vaccines, and Others), By Patient Age Group (Pediatric Vaccines (Infants, Children), Adolescent Vaccines, Adult Vaccines, and Geriatric Vaccines), By Route of Administration (Intramuscular, Intravenous, Subcutaneous, and Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 29 Apr, 2026
Code: CMI5877
Page number: 170
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Vaccine Type
  - Market Snippet, By Patient Age Group
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Driver
  - Restraints
  - Opportunities
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Mergers, Acquisitions, and Collaborations
Global Bacterial Vaccines Market, By Vaccine Type, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Pertussis (Whooping Cough) Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Tetanus Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Diphtheria Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pneumococcal Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Meningococcal Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Typhoid Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Tuberculosis (TB) Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cholera Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Shigellosis Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Global Bacterial Vaccines Market, By Patient Age Group, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Pediatric Vaccines (Infants, Children)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Adolescent Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Adult Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Geriatric Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Global Bacterial Vaccines Market, By Route of Administration, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Intramuscular
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Intravenous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Subcutaneous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Global Bacterial Vaccines Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Public
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Private
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Global Bacterial Vaccines Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Region, 2022 –2033
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Company Profie
  - GSK plc
    - Company Highlights
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Strategies
  - Pfizer Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Merck & Co., Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sanofi
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Johnson & Johnson Service, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Serum Institute of India Pvt. Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Bharat Biotech
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Biological E. Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Astellas Pharma Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Seqirus (CSL Limited)
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - AstraZeneca
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Novavax, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Bavarian Nordic A/S
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Emergent BioSolutions Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Valneva SE
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Boehringer Ingelheim International GmbH
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Immunomic Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Moderna, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Clover Biopharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Analysts’ Views
Section
- References
- Research Methodology
- About us

*Browse 43 market data tables and 41 figures on "Global Bacterial Vaccines Market” - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now